The future of toxicological testing lies in the integration of advanced technologies such as organ-on-a-chip, computational modeling, and omics technologies. These innovations aim to bridge the gap between in vitro and in vivo methods, offering more predictive, ethical, and efficient toxicity assessments. As technology evolves, these methods may reduce the reliance on animal testing while enhancing human-relevant data.
